stockrowAvantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) EPS (diluted)
Avantor, Inc.'s EPS (diluted) for fiscal 2025 was −$0.78, compared with $1.04 in fiscal 2024. Over the twelve months to 30 September 2026 it was $0.50. Over the past ten years it has ranged from −$2.75 (fiscal 2017) to $1.04 (fiscal 2024); the current reading is higher than 40% of that period. Avantor, Inc. ranks 20th of 47 Medical Instruments & Supplies companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$0.78 | — |
| FY2024 | $1.04 | 121.28% |
| FY2023 | $0.47 | (53.47%) |
| FY2022 | $1.01 | 18.82% |
| FY2021 | $0.85 | 844.44% |
| FY2020 | $0.09 | — |
| FY2019 | −$0.84 | — |
| FY2018 | −$2.69 | — |
| FY2017 | −$2.75 | — |
| FY2016 | −$0.08 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.30 | 400.00% |
| Jun 2026 | $0.06 | 0.00% |
| Mar 2026 | $0.06 | (25.00%) |
| Dec 2025 | $0.08 | — |
| 29 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| ALGN Align Technology, Inc. compare | $6.87 |
| ATR AptarGroup, Inc. compare | $4.12 |
| COO The Cooper Companies, Inc. compare | $2.93 |
| SOLV Solventum Corporation compare | $0.89 |
| AVTR Avantor, Inc. | $0.50 |
| RGEN Repligen Corporation compare | −$0.21 |
| BLCO Bausch + Lomb Corporation compare | −$0.30 |
| BAX Baxter International Inc. compare | −$1.41 |
| TFX Teleflex Incorporated compare | −$23.29 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on AVTR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement